Cas:29848-79-1 Methyl (2H31)hexadecanoate manufacturer & supplier

Chemical Name:Methyl (2H31)hexadecanoate

CAS.NO:29848-79-1

Synonyms:Hentetracontylalkohol;Methylperdeuteriopalmitat;Perdeuteriertes Methylpalmitat;1-HENTETRACONTANOL;hentriaconta-C-deuterio-hexadecanoic acid methyl ester;Methyl-perdeuterio-hexadecanoat;n-Hentetracontanol-1;Methyl (H)hexadecanoate;hentetracontanol;Hexadecanoic-d acid, methyl ester;hentetracontyl alcohol;Methyl-perdeuteriumhexadecanoat

Molecular Formula:C₁₇H₃D₃₁O₂

Molecular Weight:301.642

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:332.1±0.0 °C at 760 mmHg

Density:0.9±0.1 g/cm3

Index of Refraction:1.441

PSA:26.30000

Exact Mass:301.450470

LogP:7.62

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Hentetracontylalkohol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Methyl-perdeuteriumhexadecanoat physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Hexadecanoic-d acid, methyl ester Use and application,Methylperdeuteriopalmitat technical grade,usp/ep/jp grade.

Related News: The government is leveraging its large patient population to push non-domestic drugs companies to cut prices to their lowest level globally. Methyl (2H31)hexadecanoate manufacturer ��We believe the iLet Bionics Pancreas System represents a true breakthrough therapy for the management of glycemia, particularly in type 1 diabetes,�� said Ed Damiano, President and CEO of Beta Bionics. ��We are partuclarly excited by the possibility that the iLet may be able to provide safer and more effective therapy in far more people than current therapies due to its simplicity of use.�� Methyl (2H31)hexadecanoate supplier In March 2021, Reuters reported that a former Lilly human resources officer, Amrit Mula, had identified internally some of the same violations later documented by the FDA. Mula was forced out of the company in early 2019 after Lilly executives sought to downplay her findings, according to a letter demanding compensation for damages that her attorneys sent to the company. Methyl (2H31)hexadecanoate vendor ��With early evidence of clinical activity for our off-the-shelf, iPSC-derived NK cell programs, we are excited to lead in bringing next-generation CAR T-cell therapies to patients and plan to submit an IND for FT819 in the first half of 2020.�� Methyl (2H31)hexadecanoate factory In March 2021, Reuters reported that a former Lilly human resources officer, Amrit Mula, had identified internally some of the same violations later documented by the FDA. Mula was forced out of the company in early 2019 after Lilly executives sought to downplay her findings, according to a letter demanding compensation for damages that her attorneys sent to the company.